BPIQ Blog

Jul 17, 20231 min read

PRTA & BMS Collaboration

PRTA tech validated by big BMS collaboration • BMS is part owner of PRTA BMS & PRTA collaboration highlights: 3/20/18 CELG & PRTA enter...

Jan 4, 20235 min read

How does Lecanemab compare to other Alzheimer's assets?

Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...

May 19, 20221 min read

Q1 2022 Orbimed Biotech Hedge Fund Update

At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...

May 19, 20221 min read

Q1 2022 Perceptive Biotech Hedge Fund Update

At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...

May 16, 20222 min read

Q1 2022 EcoR1 Biotech Hedge Fund Update

At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...

Jump start your biotech due diligence

Our platform helps you uncover your next biotech investment opportunity